4.6 Article

Proteinase 3 Limits the Number of Hematopoietic Stem and Progenitor Cells in Murine Bone Marrow

Journal

STEM CELL REPORTS
Volume 11, Issue 5, Pages 1092-1105

Publisher

CELL PRESS
DOI: 10.1016/j.stemcr.2018.10.004

Keywords

-

Funding

  1. Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences [2018RC31002, 2017PT31033]
  2. Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences [2017-I2M-1-015]
  3. State Key Laboratory of Experimental Hematology Research Grant [157-Z18-01]
  4. National Basic Research Program of China [2015CB964903, 2012CB966403]
  5. National Natural Science Foundation of China [31271484, 31471116]
  6. Natural Science Foundation of Tianjin City [12JCZDJC24600]
  7. NIH [R01AI103142, R01HL092020, P01 HL095489]
  8. FAMRI [CIA 123008]

Ask authors/readers for more resources

Hematopoietic stem and progenitor cells (HSPCs) undergo self-renewal and differentiation to guarantee a constant supply of short-lived blood cells. Both intrinsic and extrinsic factors determine HSPC fate, but the underlying mechanisms remain elusive. Here, we report that Proteinase 3 (PR3), a serine protease mainly confined to granulocytes, is also expressed in HSPCs. PR3 deficiency intrinsically suppressed cleavage and activation of caspase-3, leading to expansion of the bone marrow (BM) HSPC population due to decreased apoptosis. PR3-deficient HSPCs outcompete the long-term reconstitution potential of wild-type counterparts. Collectively, our results establish PR3 as a physiological regulator of HSPC numbers. PR3 inhibition is a potential therapeutic target to accelerate and increase the efficiency of BM reconstitution during transplantation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available